Private equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisation (CDMO) Suven Pharma. Advent acquired a 50.1% stake in Suven in December 2020 for INR 6,313 crore ($866 million) and will launch an open offer for an additional 26% of the company.
Advent puts in place a new team to helm Suven Pharma - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Cytiva Delivers KUBio To Lonza
From site selection in Guangzhou Biopark to handover during the global pandemic, 17,000-square meter site was completed in less than two years
From Lonza’s first manufacturing site for biologics in China, the healthcare leader will provide services and manufacturing needed to respond to growing global pharmaceutical needs
Site to become a strategic base in China for Lonza to provide CDMO services throughout Asia Pacific region
Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider Lonza, in Guangzhou Biopark, China. The high throughput modular biomanufacturing facility will offer process development and manufacturing for Chinese companies developing innovative medicines, as well as multinationals with manufacturing requirements in China.